273 related articles for article (PubMed ID: 20606539)
21. Gynecologic Cancer InterGroup (GCIG) consensus review for uterine and ovarian carcinosarcoma.
Berton-Rigaud D; Devouassoux-Shisheboran M; Ledermann JA; Leitao MM; Powell MA; Poveda A; Beale P; Glasspool RM; Creutzberg CL; Harter P; Kim JW; Reed NS; Ray-Coquard I
Int J Gynecol Cancer; 2014 Nov; 24(9 Suppl 3):S55-60. PubMed ID: 25341582
[TBL] [Abstract][Full Text] [Related]
22. Prognostic factors for disease-free and overall survival of patients with uterine carcinosarcoma.
Şükür YE; Taşkın S; Varlı B; Ateş C; Güngör M; Ortaç F
Int J Clin Oncol; 2018 Feb; 23(1):114-120. PubMed ID: 28836024
[TBL] [Abstract][Full Text] [Related]
23. The role of lymphadenectomy in uterine carcinosarcomas (malignant mixed mullerian tumours): a critical literature review.
Vorgias G; Fotiou S
Arch Gynecol Obstet; 2010 Dec; 282(6):659-64. PubMed ID: 20721670
[TBL] [Abstract][Full Text] [Related]
24. Molecular markers and clinical behavior of uterine carcinosarcomas: focus on the epithelial tumor component.
de Jong RA; Nijman HW; Wijbrandi TF; Reyners AK; Boezen HM; Hollema H
Mod Pathol; 2011 Oct; 24(10):1368-79. PubMed ID: 21572397
[TBL] [Abstract][Full Text] [Related]
25. Long-term outcome and natural history of uterine adenosarcomas.
Arend R; Bagaria M; Lewin SN; Sun X; Deutsch I; Burke WM; Herzog TJ; Wright JD
Gynecol Oncol; 2010 Nov; 119(2):305-8. PubMed ID: 20688363
[TBL] [Abstract][Full Text] [Related]
26. Patterns of care, predictors and outcomes of chemotherapy for uterine carcinosarcoma: a National Cancer Database analysis.
Rauh-Hain JA; Starbuck KD; Meyer LA; Clemmer J; Schorge JO; Lu KH; Del Carmen MG
Gynecol Oncol; 2015 Oct; 139(1):84-9. PubMed ID: 26307402
[TBL] [Abstract][Full Text] [Related]
27. Outcome of adjuvant radiotherapy after total hysterectomy in patients with uterine leiomyosarcoma or carcinosarcoma: a SEER-based study.
Li Y; Ren H; Wang J
BMC Cancer; 2019 Jul; 19(1):697. PubMed ID: 31307426
[TBL] [Abstract][Full Text] [Related]
28. A population-based series of ovarian carcinosarcomas with long-term follow-up.
Paulsson G; Andersson S; Sorbe B
Anticancer Res; 2013 Mar; 33(3):1003-8. PubMed ID: 23482773
[TBL] [Abstract][Full Text] [Related]
29. Is there an increase in the incidence of uterine carcinosarcoma in north-east Scotland? A 19 years population-based cohort study.
Gurumurthy M; Lahiri R; Scott N; Miller I; Cruickshank ME; Parkin DE
Scott Med J; 2013 May; 58(2):88-94. PubMed ID: 23728753
[TBL] [Abstract][Full Text] [Related]
30. Rare uterine cancer: carcinosarcomas. Review from histology to treatment.
Artioli G; Wabersich J; Ludwig K; Gardiman MP; Borgato L; Garbin F
Crit Rev Oncol Hematol; 2015 Apr; 94(1):98-104. PubMed ID: 25468677
[TBL] [Abstract][Full Text] [Related]
31. Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival.
Krivak TC; Seidman JD; McBroom JW; MacKoul PJ; Aye LM; Rose GS
Gynecol Oncol; 2001 Oct; 83(1):89-94. PubMed ID: 11585418
[TBL] [Abstract][Full Text] [Related]
32. Predictive and Prognostic Factors in Ovarian and Uterine Carcinosarcomas.
Cicin İ; Özatlı T; Türkmen E; Özturk T; Özçelik M; Çabuk D; Gökdurnalı A; Balvan Ö; Yıldız Y; Şeker M; Özdemir N; Yapar B; Tanrıverdi Ö; Günaydin Y; Menekşe S; Öksüzoğlu B; Aksoy A; Erdogan B; Bekir Hacıoglu M; Arpaci E; Sevinç A
Balkan Med J; 2016 Sep; 33(5):517-524. PubMed ID: 27761279
[TBL] [Abstract][Full Text] [Related]
33. Prognostic features of surgical stage I uterine carcinosarcoma.
Ferguson SE; Tornos C; Hummer A; Barakat RR; Soslow RA
Am J Surg Pathol; 2007 Nov; 31(11):1653-61. PubMed ID: 18059221
[TBL] [Abstract][Full Text] [Related]
34. Clinical outcomes of uterine carcinosarcoma: results of 94 patients.
Gokce ZK; Turan T; Karalok A; Tasci T; Ureyen I; Ozkaya E; Kose MF; Tulunay G
Int J Gynecol Cancer; 2015 Feb; 25(2):279-87. PubMed ID: 25611900
[TBL] [Abstract][Full Text] [Related]
35. Expression and amplification of HER-2/neu oncogene in uterine carcinosarcomas: a marker for potential molecularly targeted treatment?
Raspollini MR; Susini T; Amunni G; Paglierani M; Castiglione F; Garbini F; Carriero C; Scarselli G; Taddei GL
Int J Gynecol Cancer; 2006; 16(1):416-22. PubMed ID: 16445668
[TBL] [Abstract][Full Text] [Related]
36. Uterine Sarcoma: Analysis of 13,089 Cases Based on Surveillance, Epidemiology, and End Results Database.
Hosh M; Antar S; Nazzal A; Warda M; Gibreel A; Refky B
Int J Gynecol Cancer; 2016 Jul; 26(6):1098-104. PubMed ID: 27177280
[TBL] [Abstract][Full Text] [Related]
37. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.
Amant F; Cadron I; Fuso L; Berteloot P; de Jonge E; Jacomen G; Van Robaeys J; Neven P; Moerman P; Vergote I
Gynecol Oncol; 2005 Aug; 98(2):274-80. PubMed ID: 15972232
[TBL] [Abstract][Full Text] [Related]
38. Radical surgical cytoreduction in the treatment of ovarian carcinosarcoma.
Doo DW; Erickson BK; Arend RC; Conner MG; Huh WK; Leath CA
Gynecol Oncol; 2014 May; 133(2):234-7. PubMed ID: 24631447
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of prognostic factors and treatment outcomes in uterine carcinosarcoma.
Galaal K; Kew FM; Tam KF; Lopes A; Meirovitz M; Naik R; Godfrey KA; Hatem MH; Edmondson RJ
Eur J Obstet Gynecol Reprod Biol; 2009 Apr; 143(2):88-92. PubMed ID: 19201517
[TBL] [Abstract][Full Text] [Related]
40. [Uterine Carcinosarcoma: Clinicopathological Features and Prognostic Factors].
Luz R; Ferreira J; Rocha M; Jorge AF; Félix A
Acta Med Port; 2016 Oct; 29(10):621-628. PubMed ID: 28103458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
